CV CapsoVision, Inc.

NASDAQ
$6.46

CapsoVision, Inc. (CV) is expected to report earnings on November 12, 2026, after the market close.

CapsoVision Reported Earnings
Thursday, August 13, 2026 · 4:05 PM ET
Earnings Date
Nov 12
Thursday · 4:05 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About CapsoVision, Inc.

CapsoVision is a commercial-stage medical technology company focused on developing advanced imaging and AI-enabled solutions to transform the detection and screening of gastrointestinal diseases. Its flagship product, CapsoCam Plus®, is a wire-free, panoramic capsule endoscope that enables high-resolution visualization of the small bowel and supports cloud-based or direct capsule video retrieval.

Sector

Healthcare

Industry

Healthcare Info Services

Held By 1 ETFs, by dollar flow